FindTrial
Sign In

washed and syringe-conditioned in 0.9% NaCl - 0.5% human serum albumin injection solution at a dose of 5.10^6 Mesenchymal Stromal Cells

DRUG2 trials

Sponsors

Hopital Fondation Adolphe De Rothschild, Fundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino Jesus

Conditions

AdrenoleukodystrophyPatient with severe eye chemical burns

Phase 1

OPEN-LABEL, PHASE I CLINICAL TRIAL TO EVALUATE THE SAFETY AND PRELIMINARY CLINICAL RESPONSE TO THE USE OF ALLOGENEIC BONE MARROW MESENCHYMAL STEM CELLS IN CHILDREN AND ADOLESCENTS WITH X-LINKED ADRENOLEUKODYSTROPHY CEREBRAL FORM.
Not yet recruitingCTIS2026-526701-14-00
Fundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino JesusAdrenoleukodystrophy
Target: 5Updated: 2026-10-13

Phase 2

SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre, single-arm, open-label phase II trial
Not yet recruitingCTIS2023-509713-37-00
Hopital Fondation Adolphe De RothschildPatient with severe eye chemical burns
Target: 21Updated: 2025-12-09